LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.056667
 49.63 27.76 133 4818 0.0276 0.2344
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 49.63 27.76 3189 4818 0.6619 0.8921
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 49.63 27.76 3102 4818 0.6438 0.8851
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 49.63 27.76 3231 4818 0.6706 0.8954
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 51.33 27.76 136 5117 0.0266 0.2351
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 51.33 27.76 3380 5117 0.6605 0.8928
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 51.33 27.76 3295 5117 0.6439 0.8864
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 51.33 27.76 3420 5117 0.6684 0.8957
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 53.04 27.76 96 5365 0.0179 0.1775
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 53.04 27.76 3585 5365 0.6681 0.8966
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 53.04 27.76 3517 5365 0.6555 0.8918
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 53.04 27.76 3625 5365 0.6756 0.8994
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 54.74 27.76 97 5606 0.0173 0.1775
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 54.74 27.76 3781 5606 0.6744 0.8997
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 54.74 27.76 3651 5606 0.6512 0.8911
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 54.74 27.76 3768 5606 0.6721 0.8989
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 56.45 27.76 100 5745 0.0174 0.1813
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 56.45 27.76 3962 5745 0.6896 0.9057
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 56.45 27.76 3857 5745 0.6713 0.8990
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 56.45 27.76 3984 5745 0.6934 0.9071
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 58.15 27.76 123 5906 0.0208 0.2123
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 58.15 27.76 4161 5906 0.7045 0.9114
MN20160318_Q01
D14
MCF 10A-H2B-mCherry Dasatinib
0.056667
 58.15 27.76 4026 5906 0.6816 0.9033
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 58.15 27.76 4155 5906 0.7035 0.9111
MN20160318_Q01
E11
MCF 10A-H2B-mCherry Dasatinib
0.056667
 59.85 27.76 136 6062 0.0224 0.2269
MN20160318_Q01
D14